News

Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Thailand has recorded over 50,000 new Covid-19 cases in just one week, with health officials warning that the surge, driven ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
May 21 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...